SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-029953
Filing Date
2024-03-12
Accepted
2024-03-12 16:15:42
Documents
104
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K algs-20231231.htm   iXBRL 10-K 2887732
2 EX-10.16 algs-ex10_16.htm EX-10.16 94303
3 EX-10.17 algs-ex10_17.htm EX-10.17 89400
4 EX-10.18 algs-ex10_18.htm EX-10.18 121963
5 EX-23.1 algs-ex23_1.htm EX-23.1 8907
6 EX-31.1 algs-ex31_1.htm EX-31.1 15956
7 EX-31.2 algs-ex31_2.htm EX-31.2 14933
8 EX-32.1 algs-ex32_1.htm EX-32.1 10281
9 EX-32.2 algs-ex32_2.htm EX-32.2 10834
10 EX-97.1 algs-ex97_1.htm EX-97.1 41902
11 GRAPHIC img16670836_0.jpg GRAPHIC 42170
12 GRAPHIC img16670836_1.jpg GRAPHIC 42170
13 GRAPHIC img16670836_2.jpg GRAPHIC 45431
14 GRAPHIC img16670836_3.jpg GRAPHIC 24814
15 GRAPHIC img16670836_4.jpg GRAPHIC 11788
16 GRAPHIC img16670836_5.jpg GRAPHIC 11642
17 GRAPHIC img16670836_6.jpg GRAPHIC 28167
18 GRAPHIC img16670836_7.jpg GRAPHIC 29010
19 GRAPHIC img16670836_8.jpg GRAPHIC 86374
  Complete submission text file 0000950170-24-029953.txt   12518237

Data Files

Seq Description Document Type Size
20 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT algs-20231231.xsd EX-101.SCH 1791772
106 EXTRACTED XBRL INSTANCE DOCUMENT algs-20231231_htm.xml XML 1822964
Mailing Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (800) 466-6059
Aligos Therapeutics, Inc. (Filer) CIK: 0001799448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39617 | Film No.: 24742261
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)